Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion type Assertion NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_head.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion description "[We compared the effect of control genes (CG): total Abelson (total-ABL), beta-2-microglobulin (B2M) and beta-glucuronidase (GUS), recommended in the Europe Against Cancer (EAC) program, on real-time BCR-ABL monitoring in patients with chronic myeloid leukemia (CML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion evidence source_evidence_literature NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion SIO_000772 16945414 NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion wasDerivedFrom befree-20150227 NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.
- NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_assertion wasGeneratedBy ECO_0000203 NP258508.RAcvYEOjO4AjpxsHyGNrx__fkt5XrvBRAgmPbiWMNkTT0130_provenance.